BACKGROUND AND OBJECTIVE: Verapamil is a calcium antagonist that has b
een shown to modulate wound healing through multiple mechanisms. The w
ound modulating effects of verapamil were studied in a rabbit model of
filtering surgery. MATERIALS AND METHODS: Twenty New Zealand albino r
abbits underwent a fistulizing procedure, with either verapamil or sal
ine injected subconjunctivally daily for 6 days following surgery. The
animals were sacrificed at 20 days after the fistulizing procedure. T
he effectiveness of verapamil in modulating wound healing was evaluate
d by bleb patency testing, histology, measurement of scar thickness, a
nd counts of bromodeoxyuridine (BrdU)-labeled cells at the sclerostomy
site. RESULTS: The group treated with verapamil had a 44% patency rat
e compared with 10% in the control group (P <.05), a mean scar thickne
ss of 195.96 +/- 68 mu m compared with 313.55 +/- 110.4 mu m in the co
ntrol group (P<.02), and a mean BrdU-labeled cell count of 15.5 +/- 14
.7 compared with 26.3 +/- 17.0 in the control group (P =.002). CONCLUS
ION: Verapamil was effective in reducing scar formation at the scleros
tomy site, At the doses administered, verapamil appeared to modulate w
ound healing in filtering blebs in the rabbit model. Further studies a
re needed to determine the dose-response and the efficacy of the drug
in nonhuman primates.